Chamdine Omar, Elhawary Ghada Ahmad Saad, Alfaar Ahmad Samir, Qaddoumi Ibrahim
King Fahad Specialist Hospital, Dammam, Saudi Arabia.
Ain Shams University Hospitals, Cairo, Egypt.
Childs Nerv Syst. 2018 Mar;34(3):431-439. doi: 10.1007/s00381-017-3687-4. Epub 2018 Jan 3.
Incidence of BS primitive neuroectodermal tumors (BS-PNET) in children is not reported to date. Our main objectives were to estimate the incidence and report the outcome of BS-PNET in children.
Data were collected using the Surveillance Epidemiology and End Results cancer registry.
From 1973 to 2013, we identified 83 pediatric patients (aged 0-21 years). Patients were divided into two age groups (0-3 years and 4-21 years). Median overall survival was 53 months. Patients in the older age group had a significant survival advantage (P < 0.001), as did those who received three modalities of therapy (surgery, chemotherapy, and radiation therapy) (P < 0.001) and patients with gross or subtotal tumor resection (P < 0.001).
This study presents the first estimate of incidence and the largest cohort of pediatric BS-PNETs to date. A high index of suspicion of BS-PNET in similar cases is crucial for diagnosis, treatment, and outcome.
儿童脑干原始神经外胚层肿瘤(BS-PNET)的发病率迄今尚无报道。我们的主要目的是估计儿童BS-PNET的发病率并报告其预后。
使用监测、流行病学和最终结果癌症登记处收集数据。
1973年至2013年,我们确定了83例儿科患者(年龄0至21岁)。患者分为两个年龄组(0至3岁和4至21岁)。总生存期中位数为53个月。年龄较大组的患者有显著的生存优势(P<0.001),接受三种治疗方式(手术、化疗和放疗)的患者也是如此(P<0.001),肿瘤大体或次全切除的患者同样如此(P<0.001)。
本研究首次对发病率进行了估计,并呈现了迄今为止最大的儿童BS-PNET队列。在类似病例中对BS-PNET保持高度怀疑指数对诊断、治疗和预后至关重要。